FTC investigators documented how pharmacy benefit managers imposed eye-popping markups on generic drugs used to treat deadly ...

Opinion: Miami attorney Gregg Goldfarb says wielding antitrust, fraud, and nuisance claims can help attorneys score wins in ...

The cost-plus approach, which Optum Rx said it’s rolling out now with full implementation by January 2028, would cover pharmacies’ costs to acquire branded or generic prescription drugs they ...

OptumRX, a PBM owned by UnitedHealth, also provided a statement to Fortune, asserting that its approach is cost-effective and enables the company to offer a range of services for patients with ...

UnitedHealth CEO points to hospitals, doctors and pharmaceutical companies as having a role in the high cost of health care. CEO Witty announces UnitedHealth’s OptumRX PBM will return 100% of ...

The FTC found that 22 percent of specialty drugs dispensed by PBM-affiliated pharmacies were marked up by more than 1,000 percent while 41 percent were marked up between 100 and 1,000 percent.

OptumRx pays $20M to settle federal opioid investigation The company mailed “trinity” prescriptions that raised unresolved red flags, authorities say.

UnitedHealth Group's OptumRx pharmacy benefit manager unit has agreed to pay $20 million to settle claims by U.S. authorities that it improperly filled certain opioid prescriptions, the U.S ...

The J&J lawsuit should serve as a wake-up call for employers deciding who will manage their health benefits: There's an urgent need to shift their approach in PBM evaluation and selection.

UnitedHealth's PBM, Optum Rx, launches a more 'transparent' drug pricing model Pharmacy benefit manager Optum Rx plans to launch Clear Trend Guarantee in 2025 to allow employers and health ...

UnitedHealth Group ‘s UNH OptumRx unit has a new pricing model to help manage drug costs for insurers. Starting next year, the OptumRx Clear Trend Guarantee will offer value-based pricing for drugs.